Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.

Anna C. Jansen,Elena Belousova,Mirjana P. Benedik,Tom Carter,Vincent Cottin,Paolo Curatolo,Maria Dahlin,Lisa D'Amato,Guillaume Beaure d'Augeres,Petrus J. de Vries,Jose C. Ferreira,Martha Feucht,Carla Fladrowski,Christoph Hertzberg,Sergiusz Jozwiak,John A. Lawson,Alfons Macaya,Ruben Marques,Rima Nabbout,Finbar O'Callaghan,Jiong Qin,Valentin Sander,Matthias Sauter,Seema Shah,Yukitoshi Takahashi,Renaud Touraine,Sotiris Youroukos,Bernard Zonnenberg,John C. Kingswood,Nobuo Shinohara,Shigeo Horie,Masaya Kubota,Jun Tohyama,Katsumi Imai,Mari Kaneda,Hideo Kaneko,Yasushi Uchida,Tomoko Kirino,Shoichi Endo,Yoshikazu Inoue,Katsuhisa Uruno,Ayse Serdaroglu,Zuhal Yapici,Banu Anlar,Sakir Altunbasak,Olga Lvova,Oleg Valeryevich Belyaev,Oleg Agranovich,Elena Vladislavovna Levitina,Yulia Vladimirovna Maksimova,Antonina Karas,Yuwu Jiang,Liping Zou,Kaifeng Xu,Yushi Zhang,Guoming Luan,Yuqin Zhang,Yi Wang,Meiling Jin,Dingwei Ye,Weiping Liao,Liemin Zhou,Jie Liu,Jianxiang Liao,Bo Yan,Yanchun Deng,Li Jiang,Zhisheng Liu,Shaoping Huang,Hua Li,Kijoong Kim,Pei-Lung Chen,Hsiu-Fen Lee,Jeng-Dau Tsai,Ching-Shiang Chi,Chao-Ching Huang,Kate Riney,Deborah Yates,Patrick Kwan,Surachai Likasitwattanakul,Charcrin Nabangchang,Lunliya Thampratankul Krisnachai Chomtho,Kamornwan Katanyuwong,Somjit Sriudomkajorn,Jo Wilmshurst,Reeval Segel,Tal Gilboa,Michal Tzadok,Aviva Fattal-Valevski,Panagiotis Papathanasopoulos,Antigone Syrigou Papavasiliou,Stylianos Giannakodimos,Stylianos Gatz,Evangelos Pavlou,Meropi Tzoufi,A. M. H. Vergeer,Marc Dhooghe,Helene Verhelst,Filip Roelens,Marie Cecile Nassogne,Pierre Defresne,Liesbeth De Waele,Patricia Leroy,Nathalie Demonceau,Benjamin Legros,Patrick Van Bogaert,Berten Ceulemans,Lina Dom,Pierre Castelnau,Anne De St Martin,Audrey Riquet,Mathieu Milh,Claude Cances,Jean-Michel Pedespan,Dorothee Ville,Agathe Roubertie,Stephane Auvin,Patrick Berquin,Christian Richelme,Catherine Allaire,Sophie Gueden,Sylvie Nguyen The Tich,Bertrand Godet,Maria Luz Ruiz Falco Rojas,Jaume Campistol Planas,Antonio Martinez Bermejo,Patricia Smeyers Dura,Susana Roldan Aparicio,Maria Jesus Martinez Gonzalez,Javier Lopez Pison,Manuel Oscar Blanco Barca,Eduardo Lopez Laso,Olga Alonso Luengo,Francisco Javier Aguirre Rodriguez,Ignacio Malaga Dieguez,Ana Camacho Salas,Itxaso Marti Carrera,Eduardo Martinez Salcedo,Maria Eugenia Yoldi Petri,Ramon Cancho Candela,Ines da Conceicao Carrilho,Jose Pedro Vieira,Jose Paulo da Silva Oliveira Monteiro,Miguel Jorge Santos de Oliveira Ferreira Leao,Catarina Sofia Marceano Ribeiro Luis,Carla Pires Mendonca,Milda Endziniene,Jurgis Strautmanis,Inga Talvik,Maria Paola Canevini,Antonio Gambardella,Dario Pruna,Salvatore Buono,Elena Fontana,Bernardo Dalla Bernardina,Carmen Burloiu,Iuliu Stefan Bacos Cosma,Mihaela Adela Vintan,Laura Popescu,Karel Zitterbart,Jaroslava Payerova,Ladislav Bratsky,Zuzana Zilinska,Ursula Gruber-Sedlmayr,Matthias Baumann,Edda Haberland,Kevin Rostasy,Ekaterina Pataraia,Frances Elmslie,Clare Ann Johnston,Pamela Crawford,Peter Uldall,Paul Uvebrant,Olof Rask,Marit Bjoernvold,Eylert Brodtkorb,Andreas Sloerdahl,Ragnar Solhoff,Martine Sofie Gilje Jaatun,Marek Mandera,Elzbieta Janina Radzikowska,Mariusz Wysocki,Michael Fischereder,Gerhard Kurlemann,Bernd Wilken,Adelheid Wiemer-Kruel,Klemens Budde,Klaus Marquard,Markus Knuf,Andreas Hahn,Hans Hartmann,Andreas Merkenschlager,Regina Trollmann

DOI: https://doi.org/10.3389/fneur.2019.00705

IF: 3.4

2019-01-01

Frontiers in Neurology

Abstract:Background: This study evaluated the characteristics of subependymal giant cell astrocytoma (SEGA) in patients with tuberous sclerosis complex (TSC) entered into the TuberOus SClerosis registry to increase disease Awareness (TOSCA).Methods: The study was conducted at 170 sites across 31 countries. Data from patients of any age with a documented clinical visit for TSC in the 12 months preceding enrollment or those newly diagnosed with TSC were entered.Results: SEGA were reported in 554 of 2,216 patients (25%). Median age at diagnosis of SEGA was 8 years (range, <1–51), with 18.1% diagnosed after age 18 years. SEGA growth occurred in 22.7% of patients aged ≤ 18 years and in 11.6% of patients aged > 18 years. SEGA were symptomatic in 42.1% of patients. Symptoms included increased seizure frequency (15.8%), behavioural disturbance (11.9%), and regression/loss of cognitive skills (9.9%), in addition to those typically associated with increased intracranial pressure. SEGA were significantly more frequent in patients with TSC2 compared to TSC1 variants (33.7 vs. 13.2 %, p < 0.0001). Main treatment modalities included surgery (59.6%) and mammalian target of rapamycin (mTOR) inhibitors (49%).Conclusions: Although SEGA diagnosis and growth typically occurs during childhood, SEGA can occur and grow in both infants and adults.